Virtu Financial’s Aptose Biosciences, Inc. APTO Stock Holding History

Virtu Financial’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-73	Closed	-$20K	–	2408
2022 Q3	$20K	Buy	+73	New	+$25.2K	﹤0.01%	1402
2022 Q1	–	Sell	-51	Closed	-$31K	–	2311
2021 Q4	$31K	Buy	+51	New	+$47.9K	﹤0.01%	1444
2019 Q4	–	Sell	-29	Closed	-$27K	–	1969
2019 Q3	$27K	Sell	29 -51	-64%	-$58.1K	﹤0.01%	1264
2019 Q2	$94K	Sell	80 -140	-64%	-$129K	0.01%	1143
2019 Q1	$198K	Buy	+220	New	+$199K	0.01%	1015
2018 Q1	–	Sell	-55	Closed	-$55K	–	2798
2017 Q4	$55K	Buy	+55	New	+$42.5K	﹤0.01%	2068

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Virtu Financial's APTO Position: Q4 2022 in Review

Virtu Financial sold out of Aptose Biosciences, Inc. (APTO) in Q4 2022, closing a stake of 73 shares — an estimated $20K sold.

Virtu Financial first reported a position in APTO in Q4 2017 and held it in 6 quarters. The position peaked at $198K in Q1 2019. 47 funds tracked by Wall St. Rank hold APTO as of Q4 2022.

Virtu Financial reported no remaining Aptose Biosciences, Inc. position as of Q4 2022 after selling out during the quarter.
Virtu Financial sold 73 Aptose Biosciences, Inc. shares in Q4 2022, an estimated $20K.
Virtu Financial first reported a position in Aptose Biosciences, Inc. in Q4 2017 and held it in 6 quarters.
Virtu Financial's Aptose Biosciences, Inc. position peaked at $198K in Q1 2019.
47 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.